Spitzweg C - Search Results

1

Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.

Müller AM, Schmohl KA, Knoop K, Schug C, Urnauer S, Hagenhoff A, Clevert DA, Ingrisch M, Niess H, Carlsen J, Zach C, Wagner E, Bartenstein P, Nelson PJ, Spitzweg C. Müller AM, et al. Among authors: spitzweg c. Oncotarget. 2016 Aug 23;7(34):54795-54810. doi: 10.18632/oncotarget.10758. Oncotarget. 2016. PMID: 27458162 Free PMC article.

2

The sodium iodide symporter: its pathophysiological and therapeutic implications.

Spitzweg C, Morris JC. Spitzweg C, et al. Clin Endocrinol (Oxf). 2002 Nov;57(5):559-74. doi: 10.1046/j.1365-2265.2002.01640.x. Clin Endocrinol (Oxf). 2002. PMID: 12390328 Review.

3

Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.

Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CY, Göke B, Morris JC. Spitzweg C, et al. Endocrinology. 2003 Aug;144(8):3423-32. doi: 10.1210/en.2002-0206. Endocrinology. 2003. PMID: 12865321

4

Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.

Scholz IV, Cengic N, Göke B, Morris JC, Spitzweg C. Scholz IV, et al. Among authors: spitzweg c. J Clin Endocrinol Metab. 2004 Mar;89(3):1108-16. doi: 10.1210/jc.2003-030926. J Clin Endocrinol Metab. 2004. PMID: 15001595

5

[The practical relevance of the sodium iodide symporter].

Spitzweg C. Spitzweg C. Z Arztl Fortbild Qualitatssich. 2004 May;98 Suppl 5:25-32. Z Arztl Fortbild Qualitatssich. 2004. PMID: 15255310 Review. German.

6

Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.

Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C. Scholz IV, et al. Among authors: spitzweg c. Gene Ther. 2005 Feb;12(3):272-80. doi: 10.1038/sj.gt.3302410. Gene Ther. 2005. PMID: 15510175

7

A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.

Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C. Cengic N, et al. Among authors: spitzweg c. J Clin Endocrinol Metab. 2005 Aug;90(8):4457-64. doi: 10.1210/jc.2004-2140. Epub 2005 Jun 7. J Clin Endocrinol Metab. 2005. PMID: 15941870

8

Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.

Unterholzner S, Willhauck MJ, Cengic N, Schütz M, Göke B, Morris JC, Spitzweg C. Unterholzner S, et al. Among authors: spitzweg c. J Clin Endocrinol Metab. 2006 Jan;91(1):69-78. doi: 10.1210/jc.2005-0779. Epub 2005 Oct 18. J Clin Endocrinol Metab. 2006. PMID: 16234306

9

Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.

Berger F, Unterholzner S, Diebold J, Knesewitsch P, Hahn K, Spitzweg C. Berger F, et al. Among authors: spitzweg c. Biochem Biophys Res Commun. 2006 Nov 3;349(4):1258-63. doi: 10.1016/j.bbrc.2006.08.170. Epub 2006 Sep 7. Biochem Biophys Res Commun. 2006. PMID: 16982034

10

Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.

Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Göke B, Morris JC, Spitzweg C. Willhauck MJ, et al. Among authors: spitzweg c. Breast Cancer Res Treat. 2008 May;109(2):263-72. doi: 10.1007/s10549-007-9646-0. Epub 2007 Jul 18. Breast Cancer Res Treat. 2008. PMID: 17636401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters